168 related articles for article (PubMed ID: 17442564)
1. Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.
Hata K; Dhar DK; Watanabe Y; Nakai H; Hoshiai H
Eur J Cancer; 2007 Jun; 43(9):1452-9. PubMed ID: 17442564
[TBL] [Abstract][Full Text] [Related]
2. Association of metastin/a G-protein-coupled receptor signaling and Down syndrome critical region 1 in epithelial ovarian cancer.
Hata K; Watanabe Y; Nakai H; Minami T; Ohsaki H; Hirakawa E; Hoshiai H
Anticancer Res; 2009 Feb; 29(2):617-23. PubMed ID: 19331211
[TBL] [Abstract][Full Text] [Related]
3. Expression of the angopoietin-1, angopoietin-2, Tie2, and vascular endothelial growth factor gene in epithelial ovarian cancer.
Hata K; Nakayama K; Fujiwaki R; Katabuchi H; Okamura H; Miyazaki K
Gynecol Oncol; 2004 Apr; 93(1):215-22. PubMed ID: 15047239
[TBL] [Abstract][Full Text] [Related]
4. [Expression of KiSS-1, matrix metalloproteinase-9, nuclear factor-kappaBp65 in ovarian tumour].
Gao GL; Liu LD; Zou XS; Chen WX
Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):34-8. PubMed ID: 17331419
[TBL] [Abstract][Full Text] [Related]
5. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
[TBL] [Abstract][Full Text] [Related]
6. KiSS-1 expression and metastin-like immunoreactivity in the rat brain.
Brailoiu GC; Dun SL; Ohsawa M; Yin D; Yang J; Chang JK; Brailoiu E; Dun NJ
J Comp Neurol; 2005 Jan; 481(3):314-29. PubMed ID: 15593369
[TBL] [Abstract][Full Text] [Related]
7. Metastin stimulates aldosterone synthesis in human adrenal cells.
Nakamura Y; Aoki S; Xing Y; Sasano H; Rainey WE
Reprod Sci; 2007 Dec; 14(8):836-45. PubMed ID: 18089602
[TBL] [Abstract][Full Text] [Related]
8. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
9. Effects of a KiSS-1 peptide, a metastasis suppressor gene, on the invasive ability of renal cell carcinoma cells through a modulation of a matrix metalloproteinase 2 expression.
Yoshioka K; Ohno Y; Horiguchi Y; Ozu C; Namiki K; Tachibana M
Life Sci; 2008 Aug; 83(9-10):332-8. PubMed ID: 18644390
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Endostatin gene in epithelial ovarian cancer.
Hata K; Fujiwaki R; Nakayama K; Miyazaki K
Clin Cancer Res; 2001 Aug; 7(8):2405-9. PubMed ID: 11489819
[TBL] [Abstract][Full Text] [Related]
11. Metastin and its variant forms suppress migration of pancreatic cancer cells.
Masui T; Doi R; Mori T; Toyoda E; Koizumi M; Kami K; Ito D; Peiper SC; Broach JR; Oishi S; Niida A; Fujii N; Imamura M
Biochem Biophys Res Commun; 2004 Feb; 315(1):85-92. PubMed ID: 15013429
[TBL] [Abstract][Full Text] [Related]
12. Expression of the vascular endothelial growth factor (VEGF) gene in epithelial ovarian cancer: an approach to anti-VEGF therapy.
Hata K; Watanabe Y; Nakai H; Hata T; Hoshiai H
Anticancer Res; 2011 Feb; 31(2):731-7. PubMed ID: 21378364
[TBL] [Abstract][Full Text] [Related]
13. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
14. Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression.
Motamed-Khorasani A; Jurisica I; Letarte M; Shaw PA; Parkes RK; Zhang X; Evangelou A; Rosen B; Murphy KJ; Brown TJ
Oncogene; 2007 Jan; 26(2):198-214. PubMed ID: 16832351
[TBL] [Abstract][Full Text] [Related]
15. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
Wang P; Wu X; Chen W; Liu J; Wang X
Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
[TBL] [Abstract][Full Text] [Related]
16. Expression of the thymidine phosphorylase gene in epithelial ovarian cancer.
Hata K; Kamikawa T; Arao S; Tashiro H; Katabuchi H; Okamura H; Fujiwaki R; Miyazaki K; Fukumoto M
Br J Cancer; 1999 Apr; 79(11-12):1848-54. PubMed ID: 10206303
[TBL] [Abstract][Full Text] [Related]
17. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer.
Tokunaga H; Takebayashi Y; Utsunomiya H; Akahira J; Higashimoto M; Mashiko M; Ito K; Niikura H; Takenoshita S; Yaegashi N
Acta Obstet Gynecol Scand; 2008; 87(10):1060-70. PubMed ID: 18720043
[TBL] [Abstract][Full Text] [Related]
19. High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer.
Sayer RA; Lancaster JM; Pittman J; Gray J; Whitaker R; Marks JR; Berchuck A
Gynecol Oncol; 2005 Feb; 96(2):355-61. PubMed ID: 15661221
[TBL] [Abstract][Full Text] [Related]
20. Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients.
Bignotti E; Todeschini P; Calza S; Falchetti M; Ravanini M; Tassi RA; Ravaggi A; Bandiera E; Romani C; Zanotti L; Tognon G; Odicino FE; Facchetti F; Pecorelli S; Santin AD
Eur J Cancer; 2010 Mar; 46(5):944-53. PubMed ID: 20060709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]